Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on August 3, 2026

Aug. 3, 2026

Cato Healthcare Supply Releases White Paper Introducing Revenue Preservation Procurement™ for Hospital Supply Chains

Indeterminate GlobeNewswire

Aug. 3, 2026

Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation

Indeterminate GlobeNewswire

Aug. 3, 2026

Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission

Indeterminate GlobeNewswire

Aug. 3, 2026

TOMI Environmental Solutions Receives EPA Registration Expanding SteraMist® for Use in Post-Harvest Agricultural Food Safety Including Cannabis and Hemp Cultivation

Indeterminate GlobeNewswire

Aug. 3, 2026

Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System

Indeterminate GlobeNewswire

Aug. 3, 2026

Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality

Indeterminate GlobeNewswire

Aug. 3, 2026

CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion

Indeterminate GlobeNewswire

Aug. 3, 2026

Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Canon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer Screening

Indeterminate GlobeNewswire

Aug. 3, 2026

Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company

Indeterminate GlobeNewswire

Aug. 3, 2026

CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer

Indeterminate GlobeNewswire

Aug. 3, 2026

Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome

Indeterminate GlobeNewswire

Aug. 3, 2026

Kaléo Announces License Agreement with Amgen for Auto-Injector Technology

Indeterminate GlobeNewswire

Aug. 3, 2026

Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call

Indeterminate GlobeNewswire

Aug. 3, 2026

Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures

Indeterminate GlobeNewswire

Aug. 3, 2026

Neuronetics and Jorey Chernett Announce Shared Vision

Indeterminate GlobeNewswire

Aug. 3, 2026

Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH

Indeterminate GlobeNewswire

Aug. 3, 2026

Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial Results 

Indeterminate GlobeNewswire

Aug. 3, 2026

Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Akebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases

Indeterminate GlobeNewswire